Pfizer’s vaccine against respiratory syncytial virus (RSV) may be associated with certain health problems in pregnant women, including hypertensive disorders, researchers said in a ...
RSV is a common and highly contagious seasonal illness that usually causes symptoms similar to the common cold and can also affect the lungs. Almost all children get an RSV infection before they are two years old ... For more information about RSV, visit.
More than 2 million Australians aged 75+, and Aboriginal and Torres Strait Islander people aged 60+, are now eligible for GSK's recombinant respiratory syncytial virus (RSV) adjuvanted vaccine, AREXVY, through their GP or pharmacist.
) Safety and immunogenicity of mRNA-1345 RSV revaccination at least 12 months following primary vaccination with a licensed protein subunit RSV vaccine ...Respiratory syncytial virus (RSV) is a common ...
A UK HealthSecurity Agency followed 300,000 babies born in England that found 4,500 of them were admitted to hospital - the vast majority of whom had not been vaccinated ... .
Vaccinating expectant mothers against RSV reduces hospital admissions in young infants by at least 80 per cent, according to a major study of nearly 300,000 babies in England... programme lead for RSV.
Backed by strong clinical data from the CLEVER and SMART trials showing significant reductions in RSV disease incidence and RSV-associated hospitalizations, paired with dosing convenience, ENFLONSIA ...